Morning Briefing
Summaries of health policy coverage from major news organizations
They Had A Pill -- All They Needed Was Something To Treat
Eli Lilly was about to lose its lucrative patent on Prozac. What it needed was a disorder that could be treated with anti-depressants so that it could re-brand and tap into a new marketplace. The problem was, it found a disorder that was not recognized as an actual condition by the American Psychiatric Association until years later.
Milwaukee Journal Sentinel/MedPage Today: For One Condition, The Drugs Came Before The Disorder
Beginning in 2000, the FDA approved four drugs to treat premenstrual dysphoric disorder, a form of PMS said to be so severe that it qualifies as a psychiatric condition. The hitch: It wasn't even recognized as a mental disorder until 13 years after first drug treatments were on market. (Fauber, Fiore and Wynn, 11/15)
Milwaukee Journal Sentinel/MedPage Today: Drug Used For Disorder Tied To Blood Clots, Death
A Milwaukee Journal Sentinel/MedPage Today analysis found that since 2013 alone the drugs were tied to more than 10,800 adverse events reported to FDA by health professionals and manufacturers. That included more than 200 deaths and more than 6,000 hospitalizations. (Fauber and Wynn, 11/15)
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
